What Is The Current and Historic Market Size Analysis Of The Antivirals Market?
The antivirals market has seen considerable growth due to a variety of factors.
• The size of the antivirals market has seen considerable growth in the past few years. The market is projected to increase from $106.13 billion in 2024 to $114.7 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%.
This growth during the historic period can be associated with the high occurrence of viral diseases, concerns about public health, the expiration of patents, and initiatives taken by the government.
What Are The Predictions for The Antivirals Market Size?
The antivirals market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for antivirals is anticipated to experience robust expansion in the upcoming years. It's predicted to surge to a value of $153.67 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%.
The projected growth over this period could be attributed to the rise in viral threats and worldwide health initiatives. Key trends for this forecast period involve advancements in technology, a shift towards telemedicine and digital health, as well as personalized medicine.
Which Factors Are Boosting Growth In The Antivirals Market?
The surge in occurrences of influenza is projected to drive the expansion of the antiviral market. Influenza, colloquially known as the flu, is a contagious viral infection that affects the respiratory system primarily the nose, throat, and lungs, caused by influenza viruses. Antivirals serve as a treatment method for influenza, designed to constrain the duplication and dissemination of the influenza virus within the human body. To illustrate, the Centers for Disease Control and Prevention, a health organization from the US, reported in October 2022, that there were 9 million flu diseases, 4 million medical appointments related to flu, 100,000 hospitalizations due to flu, and 5,000 deaths resulting from influenza during the 2021-2022 season. Hence, the escalating prevalence of influenza fosters the development of the antiviral market.
What Are The Core Segments Of The Global Antivirals Market?
The antivirals market covered in this report is segmented –
1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications
Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals
Pre-Book The Antivirals Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Antivirals Market Size?
Key players in the antiviral market, such as Pfizer, are striving towards the development of groundbreaking therapies like oral antiviral treatment. This effort is aimed at enhancing patient comfort, promoting accessibility, lowering healthcare expenses, and offering more efficient and convenient choices for managing viral infections. Essentially, oral antiviral treatments are medications consumed orally to combat viral infections. They function by limiting the capacity of viruses to replicate or spread inside the body, thus mitigating the intensity and span of the infection. To illustrate, in May 2023, Pfizer, a prominent pharmaceutical company headquartered in the US, announced the Food and Drug Administration's approval of Paxlovid, establishing it as the inaugural oral antiviral treatment for adult COVID-19 patients. This endorsement is particularly noteworthy as it introduces a fresh treatment alternative for managing COVID-19, particularly in a scenario where the pandemic is evolving into an endemic phase. Paxlovid is specifically prescribed for adults with mild to moderate COVID-19 who have a high likelihood of progressing to severe disease or requiring hospitalization or even leading to death.
Who Are the Key Players In The Antivirals Market?
Major companies operating in the antivirals market include:
• AbbVie Inc.
• Bristol-Myers-Squibb Co.
• Chemical Industrial & Pharmaceutical Laboratories Ltd.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson Services Ltd.
• Merck & Co. Inc.
• Dr. Reddy’s Laboratories Ltd.
• AstraZeneca plc
• Aurobindo Pharma Ltd.
• Abbott Laboratories
• Schering-Plough Corporation
• Pfizer Inc.
• Sanofi-Synthélabo Ltd.
• Regeneron Pharmaceuticals Inc.
• Inovio Pharmaceuticals Inc.
• Novavax Inc.
• BioCryst Pharmaceuticals Inc.
• Alnylam Pharmaceuticals Inc.
• Argos Distributors Limited
• AVI Biopharma International Ltd.
• Moderna Inc.
• BioNTech SE
• Eli Lilly and Company
• Takeda Pharmaceutical Company Limited
• Biogen Inc.
• Genentech USA Inc.
• Vertex Pharmaceuticals Inc.
What Are The Regional Insights Into The Antivirals Market?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
